Author Correction: Association of hepatic steatosis and liver fibrosis with chronic obstructive pulmonary disease among adults

Author Correction: Association of hepatic steatosis and liver fibrosis with chronic obstructive pulmonary disease among adults

Saved in:

Bibliographic Details
Main Authors:	Dayang Zheng, Xiang Liu, Wei Zeng, Wangyan Zhou, Chunxiang Zhou
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-06-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-025-03794-y
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Association of hepatic steatosis and liver fibrosis with chronic obstructive pulmonary disease among adults
by: Dayang Zheng, et al.
Published: (2024-05-01)

Morphogenesis of pericellular liver fibrosis in patients with chronic viral hepatitis C associated with hepatic steatosis
by: V. A. Tumanskiy, et al.
Published: (2012-08-01)

Effect of Allostatic Load on hepatic steatosis and fatty liver-associated liver fibrosis
by: Lei Zhang, et al.
Published: (2025-07-01)

Impact of hepatic steatosis on liver stiffness measurement by vibration-controlled transient elastography and its diagnostic performance for identifying liver fibrosis in patients with chronic hepatitis B
by: Zhiyuan Chen, et al.
Published: (2024-11-01)

Association of cardiometabolic markers with hepatic steatosis and liver fibrosis in population without obesity and diabetes
by: Zhixing Fan, et al.
Published: (2025-05-01)

Association between the NHHR and hepatic steatosis and liver fibrosis: a population-based study
by: Xiaoxian Yang, et al.
Published: (2025-03-01)

Effects of hepatic fibrosis on the quantification of hepatic steatosis using the controlled attenuation parameter in patients with chronic hepatitis B
by: Hee Jun Park, et al.
Published: (2025-01-01)

A study to assess hepatic steatosis and fibrosis in chronic hepatitis B patients with the help of non-invasive tests
by: Gaurav Singh, et al.
Published: (2025-07-01)

Predictors of hepatic steatosis in living liver donors
by: M. G. Minina, et al.
Published: (2022-12-01)

VCTE Overestimates Liver Fibrosis due to Abdominal–Truncal Adiposity and Not Hepatic Steatosis: A Case Report
by: Jordan S. Woodard, et al.
Published: (2024-01-01)

Long-Term Monitoring of Liver Fibrosis and Steatosis in Patients with Chronic Hepatitis C after Achieving a Sustained Virologic Response to Antiviral Therapy
by: K. R. Dudina, et al.
Published: (2023-02-01)

The occurrence of liver steatosis in patients with chronic hepatitis C - the experience of the Clinical Center of Vojvodina
by: Preveden Tomislav, et al.
Published: (2018-01-01)

Association of alpha-1 acid glycoprotein with hepatic steatosis and liver fibrosis among women: a population-based study
by: Sichang Wang
Published: (2025-08-01)

Hepatic stellate cell-specific miR-214 expression alleviates liver fibrosis without boosting steatosis and inflammation
by: Fangqing Zhao, et al.
Published: (2025-07-01)

Modeling hepatic steatosis with human adult stem cell-derived liver organoids
by: Liuyang Zhu, et al.
Published: (2025-05-01)

Interplatform Agreement Between Liver Steatosis Analysis and Ultrasound-Guided Attenuation Parameter in the Evaluation of Hepatic Steatosis
by: Chen J, et al.
Published: (2025-07-01)

Diagnostic markers of hepatic steatosis in patients with chronic viral hepatitis C
by: V. V. Tsvetkov, et al.
Published: (2023-05-01)

The influence of hepatic steatosis on the success of antiviral therapy for chronic hepatitis C
by: Preveden Tomislav, et al.
Published: (2017-01-01)

Relationships between ultrasonic, immunological changes in the progression of liver steatosis and fibrosis in patients with chronic diffusive liver diseases of various etiologies
by: Yu. M. Stepanov, et al.
Published: (2019-09-01)

Cobalt exposure was associated with the risk of hepatic steatosis and advanced liver fibrosis based on a cross-sectional study from NHANES
by: Ling Zhang, et al.
Published: (2025-03-01)

Patients with chronic hepatitis B exhibiting significant inflammation and fibrosis should pay particular attention to the status of hepatic steatosis during antiviral therapy
by: Bingqing Yang, et al.
Published: (2025-05-01)

The processes of inflammation and fibrosis in patients with chronic obstructive pulmonary disease
by: T.A. Pertseva, et al.
Published: (2020-12-01)

NFATc3 and VIP in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease.
by: Anthony M Szema, et al.
Published: (2017-01-01)

P-100 CORRELATION OF TWO TRANSIENT ELASTOGRAPHY EQUIPMENT FOR ESTIMATION OF LIVER STEATOSIS AND LIVER FIBROSIS
by: Raul Alfonso Gomez Mendoza, et al.
Published: (2024-12-01)

The association of dietary nutrients consumption with hepatic steatosis and fibrosis from NHANES 2017–2020
by: Qi Sheng, et al.
Published: (2025-06-01)

Computed Tomography Measurement of Hepatic Steatosis: Prevalence of Hepatic Steatosis in a Canadian Population
by: Malcolm M. Wells, et al.
Published: (2016-01-01)

Normative Modeling Reveals Age‐Atypical Cortical Thickness Differences Between Hepatic Steatosis and Fibrosis in Non‐Alcoholic Fatty Liver Disease
by: Minchul Kim, et al.
Published: (2025-04-01)

Diagnostic performance of FibroTouch® in assessing hepatic steatosis and fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: An Asian experience
by: Thanikan Sukaram, et al.
Published: (2025-01-01)

Assessment of Steatosis and Fibrosis in Liver Transplant Recipients Using Controlled Attenuation Parameter and Liver Stiffness Measurements
by: Ivana Mikolasevic, et al.
Published: (2021-01-01)

Antiviral therapy and regression of liver fibrosis at chronic hepatitis B
by: D. T. Abdurakhmanov
Published: (2010-02-01)

Morphogenesis of the liver fibrosis development and progression in chronic hepatitis C
by: M. A. Shishkin
Published: (2015-04-01)

Inflammatory and metabolic markers mediate the association of hepatic steatosis and fibrosis with 10-year ASCVD risk
by: Zihao Gui, et al.
Published: (2025-12-01)

Inflammatory Mediators of Hepatic Steatosis
by: Elizabeth Hijona, et al.
Published: (2010-01-01)

Differential effects of systemic immune inflammation indices on hepatic steatosis and hepatic fibrosis: evidence from NHANES 1999–2018
by: Shuyin Duan, et al.
Published: (2024-12-01)

Author Correction: The role of the apoptosis-related protein BCL-B in the regulation of mitophagy in hepatic stellate cells during the regression of liver fibrosis
by: Qian Ding, et al.
Published: (2025-07-01)

Development of hepatic steatosis in normal and veinous livers of overfed female mule ducks
by: S. Trehiou, et al.
Published: (2025-05-01)

The involvement of kidneys in chronic heart failure patients with liver steatosis
by: O. M. Drapkina, et al.
Published: (2016-02-01)

Association between dietary fatty acid intake and preserved ratio impaired spirometry in U.S. adults: a population-based cross-sectional study
by: Xiang Liu, et al.
Published: (2025-07-01)

Nine anthropometric indices predict hepatic steatosis and assess liver health in adolescents: a population-based study
by: Ruanchang Chen, et al.
Published: (2025-06-01)

Alcohol Abstinence Rescues Hepatic Steatosis and Liver Injury via Improving Metabolic Reprogramming in Chronic Alcohol-Fed Mice
by: Aiwen Pi, et al.
Published: (2021-09-01)